Thiamine pretreatment improves endotoxemia-related liver injury and cholestatic complications by regulating galactose metabolism and inhibiting macrophage activation
- 28 May 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 108, 108892
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Regression of Fibrosis and Reversal of Cirrhosis in Rats by Galectin Inhibitors in Thioacetamide-Induced Liver DiseasePLOS ONE, 2013
- Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophagesFree Radical Biology and Medicine, 2012
- Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular diseaseInternational Journal Of Clinical Practice, 2011
- Determination of hepatic galactose elimination capacity using 2-[18F]fluoro-2-deoxy-d-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver modelScandinavian Journal of Gastroenterology, 2010
- Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophagesFree Radical Biology and Medicine, 2010
- Update of Cell Damage Mechanisms in Thiamine Deficiency: Focus on Oxidative Stress, Excitotoxicity and InflammationAlcohol and Alcoholism, 2009
- Role of pulmonary intravascular macrophages in endotoxin-induced lung inflammation and mortality in a rat modelRespiratory Research, 2008
- Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammationClinical and Experimental Immunology, 2008
- Traditional Management of Liver DisordersDrugs, 1990
- Galactosamine Hepatitis, Endotoxemia, and LactuloseHepatology, 1983